Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Systems integration partner

13 May 2005 07:01

Xaar PLC13 May 2005 FOR IMMEDIATE RELEASE 13 May 2005 Xaar plc IMPIKA APPOINTED AS SYSTEMS INTEGRATION PARTNER Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, and IMPIKA SA ("IMPIKA") of Aubagne, France are pleased to announce ajoint agreement for the provision of integration services for Xaar printheadsand other products. Under the agreement both parties will co-operate to provide complete turnkeysolutions for clients wishing to use Xaar technology for their productionprocesses, to open up new applications and create bespoke solutions. IMPIKA haslong experience with inkjet, including its application to the printing ofplastic and smart cards, packaging, labelling as well as special applicationsfor printing on CDs, glass and metal. Impika is also developing solutions basedon its material jetting technology for microelectronics and biomedicalapplications. Nigel Berry, Deputy CEO of Xaar commented: "I am very pleased to announce thisrelationship with IMPIKA. We previously stated our intention to partner with asmall number of high quality integrators which can offer existing and potentialusers of our technology a complete package of integration skills and bespokeequipment. We have known the team at IMPIKA for some time now and have beenimpressed by their standards and innovation. I look forward to working withthem on future projects." Paul Morgavi, IMPIKA'S CEO said: "Xaar is a great partner for us and we arealready forming strong links with their technical and marketing teams. There isa clear synergy between Xaar and Impika with both parties introducing newmarkets into the joint relationship. Last year we introduced our C9000 productbased on Xaar's Leopard printhead and we are working on various projects foradapting our IPS print engine to the next generation of Xaar printheads, likethe Omnidot and HSS. Full commercial release of these products is anticipatedlater this year or early next year." About Xaar Xaar plc is a market-leading inkjet technology company. It targets the world'sindustrial, commercial and office printing markets. The industrial andcommercial printing markets are targeted by Xaar's own range of inkjet productsin conjunction with partners and other key players in those markets; the officeprinting market is approached through Xaar's strong list of licensees.Additional information about Xaar is available at www.xaar.co.uk. About IMPIKA: Created in March 2003 as a spin-out from Gemplus, IMPIKA is headquartered atAubagne in the south of France. IMPIKA offers high-performance industrialprinting and material jetting solutions using inkjet technology; it currentlyhas 37 employees. IMPIKA designs, develops, implements and markets hardware and softwaresolutions, as well as the required engineering as regards ink and materialjetting, for industrial applications including digital printing,microelectronics and biotechnologies. Additional information about IMPIKA isavailable at www.impika.com. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive IMPIKA: +33 (0)4 42 62 43 00Paul Morgavi, CEO www.impika.com Bankside Consultants:Steve Liebmann 020-7444-4163 /07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Oct 20137:00 amRNSPACKAGING PROGRESS UPDATE
1st Oct 201311:03 amRNSTotal Voting Rights
17th Sep 20138:46 amRNSHolding(s) in Company
16th Sep 20135:56 pmRNSHolding(s) in Company
2nd Sep 201312:07 pmRNSTotal Voting Rights
30th Aug 20134:14 pmRNSHolding(s) in Company
30th Aug 20137:00 amRNSDirector/PDMR Shareholding
29th Aug 20137:00 amRNSInterim Results
2nd Aug 20139:45 amRNSTotal Voting Rights
18th Jul 20135:05 pmRNSHolding(s) in Company
17th Jul 20135:23 pmRNSHolding(s) in Company
12th Jul 201311:43 amRNSHolding(s) in Company
11th Jul 20136:12 pmRNSHolding(s) in Company
8th Jul 201312:47 pmRNSHolding(s) in Company
28th Jun 201312:46 pmRNSHolding(s) in Company
20th Jun 20139:32 amRNSHolding(s) in Company
20th Jun 20139:31 amRNSHolding(s) in Company
10th Jun 20137:00 amRNSTrading Statement
4th Jun 20137:00 amRNSTotal Voting Rights
28th May 20133:51 pmRNSHolding(s) in Company
20th May 201312:23 pmRNSHolding(s) in Company
17th May 201311:20 amRNSGrant of Options
17th May 201311:19 amRNSAGM Result
17th May 20137:00 amRNSHolding(s) in Company
16th May 20135:56 pmRNSHolding(s) in Company
10th May 201310:18 amRNSDirector/PDMR Shareholding
2nd May 20134:11 pmRNSHolding(s) in Company
2nd May 201311:43 amRNSHolding(s) in Company
1st May 20136:23 pmRNSNotice of AGM
1st May 20136:21 pmRNSAnnual Information Update
1st May 20136:19 pmRNSDirector/PDMR Shareholding
1st May 20136:18 pmRNSTotal Voting Rights
19th Apr 20133:16 pmRNSDirector/PDMR Shareholding
17th Apr 20135:31 pmRNSHolding(s) in Company
12th Apr 20134:04 pmRNSHolding(s) in Company
12th Apr 20134:03 pmRNSHolding(s) in Company
12th Apr 20139:46 amRNSDirector/PDMR Shareholding
11th Apr 20137:00 amRNSInterim Management Statement
8th Apr 201312:45 pmRNSDirector/PDMR Shareholding
4th Apr 20133:49 pmRNSHolding(s) in Company
4th Apr 20132:53 pmRNSGrant of Options
3rd Apr 201310:42 amRNSDirector/PDMR Shareholding
2nd Apr 20139:22 amRNSTotal Voting Rights
2nd Apr 20139:19 amRNSDirector/PDMR Shareholding
25th Mar 201310:59 amRNSHolding(s) in Company
19th Mar 20137:00 amRNSFinal Results
27th Feb 20139:13 amRNSXaar first with MII 450 mm silicon wafer
15th Jan 20133:55 pmRNSHolding(s) in Company
2nd Jan 20131:37 pmRNSTotal Voting Rights
12th Dec 20127:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.